Table of Contents
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Report 2019
1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) VaccineProduct Overview
1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Comparison by Types (2014-2025)
1.2.2 Immune DTaP Vaccine
1.2.3 Therapy DTaP Vaccine
1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Comparison by Application (2014-2025)
1.3.1 Adult
1.3.2 Pediatric
1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by Region
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Comparison by Region (2014-2025)
1.4.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.5 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.6 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.7 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2025)
1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Growth Rate (2014-2025)
1.5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue and Growth Rate (2014-2025)
2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Company, Region, Type and Application
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Competition by Companies
2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Company (2014-2019)
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue by Region
2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Region (2014-2019)
2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Region (2014-2019)
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue by Type
2.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
2.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2014-2019)
2.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application
3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
3.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2019)
3.1.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
3.1.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
3.1.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
3.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
3.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
3.4 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
4.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
4.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
4.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
4.1.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
4.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
4.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
4.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
5.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue (2014-2019)
5.1.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
5.1.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
5.1.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
5.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
5.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
5.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
6.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
6.1.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
6.1.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
6.1.3 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
6.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
6.3 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
7.1 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
7.1.1 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
7.2 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
7.3 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
7.4 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price
8.1 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Value (2014-2019)
8.1.1 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
8.1.2 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019)
8.1.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend (2014-2019)
8.2 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company
8.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
8.4 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application
9 Company Profiles and Key Figures in Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business
9.1 Sanofi Pasteur
9.1.1 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Protein Sciences Corporation
9.3.1 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Novartis AG
9.4.1 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Seqirus
9.5.1 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Merck Sharp & Dohme Corp
9.6.1 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.6.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Astellas Pharma US, Inc
9.7.1 Astellas Pharma US, Inc Production Sites and Area Served
9.7.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Pfizer Inc
9.8.1 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Johnson & Johnson
9.9.1 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.9.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 Lanzhou Institute of Biological Products Co., Ltd
9.10.1 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
9.10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Specification and Application
9.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
9.11 AstraZeneca
9.12 Emergent BioSolutions Inc
10 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Maufacturing Cost Analysis
10.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industrial Chain Analysis
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
11.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors
13 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast
13.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Price Forecast
13.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Forecast (2019-2025)
13.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Forecast (2019-2025)
13.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend Forecast (2019-2025)
13.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Region
13.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Type
13.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type (2019-2025)
13.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Type (2019-2025)
13.3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Forecast by Type (2019-2025)
13.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Application
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
【免責事項】
https://www.globalresearch.jp/disclaimer